Locations:
Min Investment:
Max Investment:
Target Investment:
(1991 - 1991)
2023
2023
2016
2015
2015
2017
2017
2014
2014
2015 - 2023
2015 - 2023
Board member until merger with Erytech and creation of Phaxiam Therapeutics (PHXM)
2021 - 2023
2021 - 2023
Board member until I left Elaia Partners
2019 - 2023
2019 - 2023
Board member until I left Elaia Partners
2018 - 2023
2018 - 2023
2020 - 2022
2020 - 2022
Finalized the financing seed round and transmitted the follow-up to the team after 2 years of board membership post seed round.